Effects of storage and viral load on hepatitis C viral genotyping
Open Access
- 6 November 2001
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 15 (6) , 331-333
Abstract
Hepatitis C virus (HCV) genotyping is important for determining the treatment protocol for hepatitis C patients. Since amplified material from the Roche HCV Monitor kit is compatible with the Innogenetics INNO‐LiPA HCV II kit (line probe assay), amplicons from the Monitor assay can be used to identify the HCV genotype. The Monitor package insert recommends using amplicons within a 7‐day period (at 4°C) following amplification. It was hypothesized that storage of amplicons for 4 weeks and longer (at –20°C) would not affect the sensitivity of the genotyping assay. After denaturation, amplicons from two genotypes were stored for 7–386 days prior to performing the genotyping assay. Storage of amplicons did not hamper the ability to identify the genotype. Additionally, the sensitivity of the assay was evaluated by analyzing five genotypes with low viral loads. HCV genotypes were detected most consistently at viral levels of 10,000 copies/mL. In conclusion, the Innogenetics genotyping assay can use stored amplicons, thus reducing the cost of the assay by avoiding additional PCR reactions. Determining the sensitivity of this assay facilitates the efficient use of this test by incorporating a sensitivity cutoff of ≥10,000 copies/mL. J. Clin. Lab. Anal. 15:331–333, 2001. © 2001 Wiley‐Liss, Inc.Keywords
This publication has 13 references indexed in Scilit:
- Cost effectiveness of interferon α2b combined with ribavirin for the treatment of chronic hepatitis CHepatology, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusThe Lancet, 1998
- Hepatitis C Virus Type 1b (II) Infection in France and ItalyAnnals of Internal Medicine, 1995
- Factors predictive of response to interferon-α therapy in hepatitis C virus infectionHepatology, 1994
- Prediction of response to interferon treatment of chronic hepatitis CJournal of Hepatology, 1994
- At least five related, but distinct, hepatitis C viral genotypes exist.Proceedings of the National Academy of Sciences, 1992
- Detection of Hepatitis C Virus by Polymerase Chain Reaction and Response to Interferon–α Therapy: Relationship to Genotypes of Hepatitis C VirusHepatology, 1992
- Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variantsJournal of General Virology, 1992
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989